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Abstract
Purpose The aim of this study was to determine the diagnostic value of 18F–fluorodeoxyglucose (FDG) positron emission
tomography and computed tomography (PET/CT) and magnetic resonance imaging (MRI) in diagnosing vertebral osteomyelitis.
Methods From November 2015 until December 2016, 32 patients with suspected vertebral osteomyelitis were prospectively
included. All patients underwent both 18F–FDG-PET/CT and MRI within 48 h. All images were independently reevaluated by
two radiologists and two nuclear medicine physicians who were blinded to each others’ image interpretation. 18F–FDG-PET/CT
and MRI were compared to the clinical diagnosis according to international guidelines.
Results For 18F–FDG-PET/CT, sensitivity, specificity, PPV, and NPV in diagnosing vertebral osteomyelitis were 100%, 83.3%,
90.9%, and 100%, respectively. For MRI, sensitivity, specificity, PPV, and NPV were 100%, 91.7%, 95.2%, and 100%, respec-
tively. MRI detected more epidural/spinal abscesses. An important advantage of 18F–FDG-PET/CT is the detection of metastatic
infection (16 patients, 50.0%).
Conclusion 18F–FDG-PET/CT and MRI are both necessary techniques in diagnosing vertebral osteomyelitis. An important
advantage of 18F–FDG-PET/CT is the visualization of metastatic infection, especially in patients with bacteremia. MRI is more
sensitive in detection of small epidural abscesses.
Keywords Vertebral osteomyelitis . 18F–Fdg-pet/ct . MRI .
Abscesses
Introduction
Vertebral osteomyelitis is a severe infection of the spine and its
prevalence is increasing in our aging society [1]. Common
complications of vertebral osteomyelitis are epidural, spinal,
or psoas abscesses. Epidural/spinal abscesses may result in
paraplegia if they are not diagnosed and treated promptly.
One third of patients with vertebral osteomyelitis suffer from
residual spinal dysfunction or persistent pain after recovery [2,
3]. Therefore, early and accurate detection of vertebral osteo-
myelitis is necessary for improved outcome [4]. Symptoms
and signs of vertebral osteomyelitis, however, are often un-
specific and diagnosis is difficult. Magnetic resonance imag-
ing (MRI) is most often used as imaging technique in diag-
nosing vertebral osteomyelitis [5] with a reported sensitivity
and specificity of more than 90% [6, 7]. Disadvantages of
MRI are artifacts due to metallic implants, occasional similar-
ities between vertebral osteomyelitis and degenerative disease
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[8], and reduced sensitivity in patients with short duration of
symptoms [8, 9].
Combined 18F–fluorodeoxyglucose (FDG) positron emis-
sion tomography and computed tomography (PET/CT) is in-
creasingly used in diagnosing infectious diseases. In patients
suspected of vertebral osteomyelitis, the first studies on the
value of 18F–FDG-PET (without combined CT) showed high
sensitivity and specificity up to 100% [10–12]. The value of
18F–FDG-PET/CT in patients with vertebral osteomyelitis has
been studied [13] and also compared to MRI [14, 15].
However, in these studies, the time between start of symptoms
and moment of imaging was not mentioned and time between
18F–FDG-PET/CT and MRI is also unknown. The purpose of
this study was to prospectively compare the diagnostic value
of MRI and 18F–FDG-PET/CT in diagnosing vertebral osteo-
myelitis and its complications with a maximum time interval
of 48 h between imaging techniques.
Materials and methods
Patients
In this prospective study at the Radboud University Medical
center and at the Leiden University Medical Center, all adult
patients with clinically suspected vertebral osteomyelitis from
November 2015 to December 2016 were included. Vertebral
osteomyelitis was suspected in case of fever and back pain, in
case of bacteremia and back pain, or when there was an in-
creased C-reactive protein (CRP) or erythrocyte sedimenta-
tion rate (ESR) and back pain. Exclusion criteria were preg-
nancy, known metastases in the spine, poorly regulated diabe-
tes mellitus, too ill for transportation to 18F–FDG-PET/CT
and/or MRI, and absolute contra-indications for MRI. Both
18F–FDG-PET/CT and MRI were performed in all patients
within 48 h from each other and with a preferable interval of
no more than 24 h. In case of negative blood cultures, CT-
guided biopsy of the spine was strongly recommended by the
study physician in all patients. If the CT-guided biopsy was
inconclusive, open biopsy by the orthopedic surgeon was
strongly recommended. MRI was repeated after 2 weeks if
18F–FDG-PET/CT showed abnormalities suggestive of verte-
bral osteomyelitis, and the first MRI was negative. The insti-
tutional review board approved this study and informed con-
sent was waived.
18F–FDG-PET/CT and MRI
Two integrated PET/CTscanners (Biograph 40mCT; Siemens
Healthcare and Gemini TF64; Philips) were used. All patients
were on a low carbohydrate-fat allowed diet 24 h before 18F–
FDG-PET/CTwas performed, and they fasted 6 h before 18F–
FDG-injection. Blood glucose levels were required to be less
than 12 mmol/l in all patients, including in diabetic patients.
One hour after intravenous injection of a 3.3 MBq/kg average
dose of 18F–FDG (Mallinckrodt Pharmaceuticals, Petten, the
Netherlands or IBAMolecular, Amsterdam, the Netherlands),
whole-body low-dose CTscan was acquired for anatomic cor-
relation and attenuation correction of the PET data.MRI of the
spine was performed using 1.5 T systems (Siemens, Erlangen,
Germany, and Philips, Best, the Netherlands).
Follow-up
Patients who were diagnosed with vertebral osteomyeli-
tis based on at least one imaging study and/or blood or
tissue culture results were treated with antibiotics for
6 weeks according to the IDSA (Infectious Diseases
Society of America) guideline for vertebral osteomyelitis
[16]. In case of other infectious foci with subsequent
indication for longer duration of antibiotic treatment
(i.e., vascular graft infection or prosthetic joint infec-
tion), patients were treated longer than 6 weeks.
Three months after inclusion, all surviving patients visited
the outpatient clinic for evaluation of symptoms. Patients were
considered to be cured when there were no symptoms or signs
of infection (i.e., fever, persistently increased CRP, persistent
positive blood cultures, persistent back pain) after discontinu-
ation of antibiotic treatment. Persistent infection was consid-
ered to be present when patients were still treated for vertebral
osteomyelitis at three month follow-up without resolution of
the described symptoms. Relapse of infection was defined as a
second episode of vertebral osteomyelitis with the same caus-
ative micro-organism after completion of adequate antibiotic
treatment of at least six weeks duration. Mortality was consid-
ered to be infection related when a patient died during the
episode of vertebral osteomyelitis with persistent signs or
symptoms of systemic infection or after relapse without an-
other possible cause of death.
Evaluation of imaging
All 18F–FDG-PET/CT scans were evaluated after the in-
clusion period by two independent nuclear medicine phy-
sicians without knowledge of the clinical context of pa-
tients by using the score as mentioned in Table 1.
Disagreements were resolved by consensus afterwards.
All MRI scans were evaluated by two independent radi-
ologists without knowledge of the clinical context of pa-
tients. Both radiologists had many years of experience and
were specifically trained for musculoskeletal imaging. For
evaluation of MRI the score as mentioned in Table 1 was
used. Disagreements were resolved by consensus after-
wards. The original reports and the revised reports were
evaluated using the following parameters: sensitivity,
specificity, positive predictive value (PPV), and negative
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predictive value (NPV). The results of imaging (both orig-
inal and revised reports) were compared with the clinical
diagnosis as reference standard according to the IDSA
guideline for vertebral osteomyelitis [16]. As the gold
standard for the diagnosis, we defined vertebral osteomy-
elitis, in accordance with the IDSA guideline, as new back
pain plus positive tissue/blood culture plus at least one
positive imaging outcome. Original imaging reports were
compared to revised imaging reports to investigate the
need of an expert opinion in evaluation of imaging in
suspected vertebral osteomyelitis and also in relation to
the duration of symptoms. The primary outcome parame-
ters were sensitivity, specificity, PPV, and NPV of both
original and revised reports of 18F–FDG-PET/CT and
MRI for the diagnosis of vertebral osteomyelitis. A sec-
ondary outcome parameter was detection of epidural/
spinal abscesses, paravertebral abscesses, and psoas
abscesses.
Statistics
All data were collected in a structured database using SPSS
statistics (version 20.0; IMB Corp.) and diagnostic value of
both original and revised reports of 18F–FDG-PET/CT and
MRI was determined by calculating sensitivity, specificity,
PPV, NPV, and 95% confidence interval (CI).
Results
Patients
A total of 32 patients were included. Baseline charac-
teristics of all patients are shown in Table 2. All pa-
tients included in the study had community-acquired
infections. Vertebral osteomyelitis was diagnosed in 20
patients and this diagnosis was made according to the
IDSA guideline [16]. In 12 patients without vertebral
osteomyelitis the following diagnoses were made based
on imaging and clinical findings; degenerative spinal
disease in five patients, and single patients had
tendomyalgia, spinal metastases of urothelial carcinoma,
infected aortic aneurysm, pyelonephritis, Charcot spine,
infected spinal osteosynthesis of sacroiliac joints without
vertebral osteomyelitis, and immobilization due to se-
vere dyskeratosis follicularis (Darier’s disease). Four pa-
tients with vertebral osteomyelitis died of whom three
were infection-related, because these patients died due
to complications of the infection, one patient died due
to severe myelodysplastic syndrome. No relapses oc-
curred within 3 months after treatment. Treatment was
continued after 3 months in eight patients (38.1%). Two
patients without the diagnosis of vertebral osteomyelitis
died, one patient due to metastasized urothelial carcino-
ma and one patient due to liver cirrhosis.
Table 1 Five-point grading score for assessment of 18F–FDG-PET/CT and MRI in suspected vertebral osteomyelitis
18F–FDG-PET/CT MRI
Score 0a Normal findings and physiological
18F–FDG distribution
Normal findings except for degeneration
Score 1a Minimal increased 18F–FDG uptake
compared to normal bone marrow 18F–
FDG uptake
Minimal decreased SI T1 and increased SI
T2 and enhancement in intervertebral or
paravertebral region compared to normal
bone marrow
Score 2Ab Increased 18F–FDG uptake with a linear
or disciform pattern in intervertebral
disc space
Decreased SI T1 and increased SI T2 and
enhancement with linear or disciform
pattern at intervertebral disc space
Score 2Bb Increased 18F–FDG uptake in only ossal
structures without pathological changes
in intervertebral discs
Decreased SI T1 and increased SI T2 and
enhancement in only ossal structures,
without changes in intervertebral discs
Score 3c Increased 18F–FDG uptake with a linear
or disciform pattern in intervertebral
disc space and involvement of endplate
(or adjacent vertebrae)
Decreased SI T1 and increased SI T2 at
intervertebral disc space and involvement
of endplate (or adjacent vertebrae)
Score 4c Increased 18F–FDG uptake with a linear
or disciform pattern in intervertebral
disc space and involvement of endplate
with surrounding soft tissue abscesses
Decreased SI T1 and increased SI T2 at
intervertebral disc space and involvement
of endplate with surrounding soft tissue
abscesses.
a Score 0 and 1 were considered as normal or aspecific and excluded vertebral osteomyelitis
b Score 2Awas considered as discitis and score 2B as osteomyelitis (without discitis)
c Score 3 and 4 were considered as vertebral osteomyelitis
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MRI and 18F–FDG-PET/CT
In eight patients (25.0%) MRI and 18F–FDG-PET/CT
were performed on the same day, in 18 patients
(56.3%) within 24 h, and in six patients (18.8%) after
24 h but within 48 h. The median time interval between
first symptoms and imaging was 24.9 days with a range
of 3–120 days. Fifteen patients (46.9%) had symptoms
less than 14 days and six patients (18.8%) less than
seven days.
Of all original reports of MRI scans, 29 reports had
the same conclusion compared to reevaluation by an
expert panel (90.6%). Of all original reports of 18F–
FDG-PET/CT, 31 reports had the same conclusion com-
pared to reevaluation by an expert panel (96.9%). In
one patient, the original 18F–FDG-PET/CT report was
true negative, while reevaluation was false positive for
vertebral osteomyelitis. MRI did not show vertebral os-
teomyelitis in this patient. This patient had chronic Q
fever with an infected endovascular aortic repair
(EVAR) without vertebral osteomyelitis.
Two original MRI reports discarded a diagnosis of
vertebral osteomyelitis while reevaluation did show ver-
tebral osteomyelitis. These two patients had back pain
for 10 and 7 days before the first moment of imaging
and repeated MRI after 14 days confirmed vertebral
osteomyelitis in both (Fig. 1). In one patient with
S. aureus bacteremia and endocarditis, the original
MRI report concluded vertebral osteomyelitis and re-
evaluation excluded vertebral osteomyelitis. In this
Table 2 Baseline characteristics of patients with and without vertebral osteomyelitis
All patients
(n = 32)
Patients with vertebral
osteomyelitis (n = 20)
Patients without vertebral
osteomyelitis (n = 12)
Male (%) 22 (68.8) 16 (80.0) 6 (50.0)
Age (range) 66.8 (43–92) 70.2 (43–92) 61.1 (46–81)
Medical history
- Malignancy (%) 4 (12.5) 2 (10.0) 2 (16.7)
- Immunocompromized (%) 2 (6.3) 2 (10.0) 0
- Diabetes mellitus (%) 4 (12.5) 3 (15.0) 1 (8.3)
- Spinal implants (%) 2 (6.3) 0 2 (16.7)
- Spinal surgery <1y (%) 1 (3.1) 0 1 (8.3)
- Other implantsa (%) 10 (31.3) 6 (30.0) 4 (33.3)
Fever (%) 23 (71.9) 14 (70.0) 8 (66.7)
Increased CRP/ESR (%) 31 (96.9) 20 (100) 11 (91.7)
Positive blood cultureb (%) 26 (81.3) 18 (85.7) 8 (72.7)
a Other implants: vascular graft (n = 4), heart valve prosthesis (n = 2), total hip prosthesis (n = 2), double J stent (n = 1), sacral neuromodulator (n = 1)
b 11 patients (42.3%) had Staphylococcus aureus bacteremia, one patient (3.8%) had bacteremia with coagulase-negative Staphylococcus, eight patients
(30.8%) had bacteremia with Streptococcus species, two patients (7.7%) with Enterococcus faecalis, two patients (7.7%) with Escherichia coli, and one
patient (3.8%) with Klebsiella pneumoniae, and one patient (3.8%) with Aerococcus urinae
Fig. 1 Imaging of the lumbar spine of a 43-year-old woman on
haemodialysis who was admitted because of S. aureus bacteremia and
back pain. 18F–FDG-PET (a) and 18F–FDG-PET/CT (c) showing
increased 18F–FDG uptake of T12-L1 (score 4). T1-weighted Gd-
chelate enhanced MRI (b) showing subtle enhancement of the
intervertebral disc at level T12-L1 and of the perivertebral soft tissues
and subtle interruption of the anterior endplates of T12 and L1 (score 4).
The original MRI report was false-negative indicating a psoas abscess but
no vertebral osteomyelitis. Original 18F–FDG-PET/CT and also
reevaluated 18F–FDG-PET/CT and MRI did show vertebral
osteomyelitis on level T12-L1. Repeated MRI after 2 weeks also
confirmed the diagnosis of vertebral osteomyelitis
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patient, back pain was asserted as degenerative disc dis-
ease as stated by the reevaluated MRI report and 18F–
FDG-PET/CT reports (Fig. 2). When comparing diag-
nostic values of imaging performed within 14 days after
start of symptoms and imaging performed after 14 days
after start of symptoms, diagnostic values for MRI per-
formed within 14 days were higher for revised imaging
reports compared to original MRI reports (Table 3). For
18F–FDG-PET/CT and all imaging performed after
14 days after start of symptoms there were no important
differences between original and revised results.
For MRI and 18F–FDG-PET/CT in diagnosing verte-
bral osteomyelitis, overall sensitivity, specificity, PPV,
and NPV are shown in Table 4. In one patient without
the clinical diagnosis of vertebral osteomyelitis but with
a Charcot spine 18F–FDG-PET/CT and MRI which were
both false-positive, showing signs of vertebral osteomy-
elitis with surrounding abscesses. Biopsy of the soft
tissue involvement was performed and culture was neg-
ative as well as PCR (polymerase chain reaction) for
Coxiella burnetii and bacterial 16S rDNA PCR. This
patient is in good condition without any use of antibi-
otics, now eight months after imaging.
Diagnosing abscesses
Vertebral osteomyelitis with abscesses was found in 11
out of 20 patients. Five patients had epidural and spinal
abscesses, nine patients had paravertebral abscesses, and
four patients had psoas abscesses. With MRI all five
Fig. 2 18F–FDG-PET/CT and MRI of a 61-year-old man who was
admitted with S. aureus endocarditis and back pain. 18F–FDG-PET (a),
CT (b), and 18F–FDG-PET/CT (c) showing degenerative changes on
level T3-T4 and L2-L3. T1-weighted Gd-chelate enhanced MRI (d, e),
pre- and postcontrast, showing Modic type 1 degenerative changes at
level T3–4 and L2-L3. In the original MRI report a diagnosis of
vertebral osteomyelitis on the levels T3-T4 and L2-L3 was made, 18F–
FDG-PET/CT was negative for vertebral osteomyelitis. Reevaluation of
18F–FDG-PET/CT and MRI were both negative (score 1) and long-term
follow-up confirmed that the back pain could be attributed to
degenerative changes of the spine
Table 3 Diagnostic results of original and revised reports of imaging in 20 patients with early (< 14 days of symptoms) and late (> 14 days of
symptoms) stage of vertebral osteomyelitis
MRI 18F–FDG-PET/CT
Original report Revised report Original report Revised report
< 14 days
Sensitivity 77.8% (40.0–97.2) 100% (66.4–100) 100% (66.4–100) 100% (66.3–100)
Specificity 83.3% (35.9–99.6) 100% (54.1–100) 100% (54.1–100) 83.3% (35.9–99.6)
PPV 87.5% (53.1–97.7) 100% (70.1–100) 100% (70.1–100) 90.0% (60.1–98.2)
NPV 71.4% (41.6–89.9) 100% (61.0–100) 100% (61.0–100) 100% (56.6–100)
> 14 days
Sensitivity 100% (71.5–100) 100% (71.5–100) 100% (71.5–100) 100% (71.5–100)
Specificity 83.3% (35.9–99.6) 83.3% (35.9–99.6) 83.3% (35.9–99.6) 83.3% (35.9–99.6)
PPV 91.7% (64.8–98.5) 91.7% (64.8–98.5) 91.7% (64.8–98.5) 91.7% (64.8–98.5)
NPV 100% (56.6–100) 100% (56.6–100) 100% (56.6–100) 100% (56.6–100)
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and with 18F–FDG-PET/CT only one epidural/spinal ab-
scesses were detected. With 18F–FDG-PET/CT five out
of nine paravertebral abscesses and with MRI seven out
of nine abscesses were detected. 18F–FDG-PET/CT de-
tected all four psoas abscesses. MRI detected three out
of four psoas abscesses, as on one MRI the iliopsoas
was not fully included in the field of view.18F–FDG-
PET/CT detected metastatic infection in 16 patients
(50.0%) and 18F–FDG-PET/CT was the first to localize
infectious foci other than vertebral osteomyelitis in 14
of these patients (87.5%). Localizations of metastatic
infection were joints (43.8%), pulmonary foci (18.8%),
soft tissue (18.8%), endovascular (12.5%), and spleen
(6.3%).
Discussion
MRI and 18F–FDG-PET/CT are both valuable in diagnosing
vertebral osteomyelitis. Our study shows high sensitivity and
specificity for both imaging techniques, without a significant
difference between 18F–FDG-PET/CT and MRI.
Earlier studies on the diagnosis of vertebral osteomye-
litis reported a sensitivity and specificity of 83% and 88%
for 18F–FDG-PET/CT and 94% and 38% for MRI [14]
and a sensitivity and specificity of 82% and 100% for
18F–FDG-PET/CT and 75% and 72% for MRI [15].
Smids et al. [17] retrospectively investigated the diagnos-
tic value of 18F–FDG-PET/CT and MRI in patients
suspected of vertebral osteomyelitis and reported a sensi-
tivity and specificity of 96% and 95% for 18F–FDG-PET/
CT and 67% and 84% for MRI. This study also showed
that the diagnostic accuracy for MRI improved when MRI
was performed at least 14 days after start of symptoms
compared to MRI performed within 14 days after onset of
symptoms (82% and 58%, respectively). In the study of
Smids et al., there was no significant difference in accu-
racy in relation to the moment of imaging for 18F–FDG-
PET/CT (94% and 97%, respectively) [17]. In the current
study, original reports of MRI performed within 14 days
showed, although not significantly, lower diagnostic value
compared to when MRI was performed after 14 days after
start of symptoms (Table 3). However, revision of MRI by
an expert panel reversed these differences. This empha-
sizes the importance of an expert panel for assessment of
MRI in suspected vertebral osteomyelitis. Overall, we
found a higher diagnostic value for MRI in suspected
vertebral osteomyelitis in the current study compared to
MRI studies published earlier [6, 7]. This might be partly
due to the fact that reevaluation was performed by a panel
of experts on musculoskeletal imaging including vertebral
osteomyelitis and by using a structured scoring system
(Table 1). Because in the study of Smids et al., only orig-
inal reports of imaging were used (reflecting daily clinical
practice), the conclusion of MRI having a lack of accura-
cy in the very early stage of vertebral osteomyelitis might
change when revision of all imaging would have been
performed by an expert panel using a structured scoring
system. This is an important message for clinical practice,
as in case of a highly suspected vertebral osteomyelitis
with negative MRI, an expert opinion is highly recom-
mended, especially in case of a short duration of
symptoms.
In our study, MRI and 18F–FDG-PET/CT were false-
positive in a patient with a Charcot spine. Charcot spine, or
neuropathic arthropathy, is a known condition to be mistaken
for infection on MRI [18].
In the study of Smids et al. [17], MRI was the modality of
choice to diagnose epidural and spinal abscesses with a sensi-
tivity of 93%. 18F–FDG-PET/CT showed higher sensitivity in
diagnosing paravertebral (94%) and psoas abscesses (100%)
compared to MRI (61% and 63%, respectively). Our study
confirmed that MRI is more valuable in detecting epidural
and spinal abscesses compared to 18F–FDG-PET/CT.
An important advantage of 18F–FDG-PET/CT com-
pared to MRI is tha t meta l l ic implants are no
Table 4 Diagnostic results of
18F–FDG-PET/CT and MRI for
diagnosing vertebral
osteomyelitis
18F–FDG-PET/CT (n = 32) MRI (n = 32)
Diagnosis of vertebral osteomyelitis 20 20
No. of true-positive results 20 20
No. of false-positive results 2 1
No diagnosis of vertebral osteomyelitis 12 12
No. of true-negative results 10 11
No. of false-negative results 0 0
Sensitivity (95% CI) 100% (79.9–100) 100% (79.9–100)
Specificity (95% CI) 83.3% (50.9–97.1) 91.7% (60.0–99.6)
PPV (95% CI) 90.9% (69.4–98.4) 95.2% (74.1–99.8)
NPV (95% CI) 100% (65.5–100) 100% (67.9–100)
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contraindication and do not cause severe artifacts.
Furthermore, 18F–FDG-PET/CT imaging detected meta-
static infection that often needed further interventions
and treatment. 18F–FDG-PET/CT has proven its effective-
ness in patients with Gram-positive bacteremia and infec-
tive endocarditis for detecting metastatic infection with a
reduction of relapse and mortality rates [19, 20]. In our
study, 18F–FDG-PET/CT detected metastatic foci in
50.0% of patients, 87.5% of those foci being asymptom-
atic. Because we did not use whole-body MRI, MRI was
not able to detect metastatic infection in this study. 18F–
FDG-PET/CT could also differentiate between infection
and degeneration [11]. Degeneration may occasionally re-
semble infectious vertebral osteomyelitis on MRI because
of the presence of bone marrow edema, which may make
MRI interpretation challenging [18]. Assessment of 18F–
FDG-PET/CT is, due to the clear guidance of increased
18F–FDG uptake, more straight forward than assessment
of MRI, which is an important advantage in daily clinical
practice.
The new imaging technique 18F–FDG-PETcombined with
MRI could be an excellent combination of 18F–FDG-PET/CT
and MRI and thereby combining the high diagnostic value,
detection of metastatic infection and small abscesses. The first
study on the value of 18F–FDG-PET/MRI in patients
suspected of vertebral osteomyelitis was published by
Fahnert et al. [21]. Sensitivity, specificity, PPV, and NPV for
18F–FDG-PET/MRI in the study of Fahnert et al. were 100%,
88%, 86%, and 100%, respectively, and they concluded 18F–
FDG-PET/MRI increases the diagnostic certainty for the de-
tection of vertebral osteomyelitis. Diagnostic value for detec-
tion of abscesses was not reported. In the study of Fahnert
et al., only patients with earlier inconclusive MRI were
included.
In our study, assessment of 18F–FDG-PET/CT and MRI
was performed using a 5-point grading score (Table 1). In all
other studies performed on the value of 18F–FDG-PET/CT in
suspected vertebral osteomyelitis, no structured grading score
was used. Our 5-point grading score could be a practical ap-
proach for assessment of both 18F–FDG-PET/CT and MRI in
suspected vertebral osteomyelitis to provide a more structured
evaluation of imaging.
In conclusion, 18F–FDG-PET/CT and MRI are both neces-
sary techniques in diagnosing vertebral osteomyelitis. An im-
portant advantage of 18F–FDG-PET/CT is insensitivity to
metal artifacts, the large field of view allowing diagnosis of
regional abscesses (that can be missed on small field of view
MRI) and metastatic infections, especially in patients with
bacteremia. MRI is more sensitive in detection of small epi-
dural abscesses. Integrated 18F–FDG-PET/MRI in a ‘one-
stop-shop’ combines these qualities and could, therefore, be-
come the imaging technique of choice in suspected vertebral
osteomyelitis.
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